カテゴリー： QYResearch, 世界

月経前不快気分障害（PMDD）の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18853）・商品コード：DATA909X18853
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、月経前不快気分障害（PMDD）の世界市場について調査・分析し、月経前不快気分障害（PMDD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の月経前不快気分障害（PMDD）市場動向
・主要企業別マーケットシェア
・月経前不快気分障害（PMDD）の種類別市場規模2014-2019
（テーブル製品、インジェクト製品、その他）
・月経前不快気分障害（PMDD）の用途別市場規模2014-2019
（病院、診療所、その他）
・月経前不快気分障害（PMDD）の北米市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）のヨーロッパ市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の中国市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の日本国内市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の東南アジア市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）のインド市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Teva、Eli Liliy、Pfizer、Bayer、GSK、Apotex、Bristol Laboratories、Mylan、Allergan）
・月経前不快気分障害（PMDD）の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.In 2018, the global Premenstrual Dysphoric Disorder (PMDD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan

Market segment by Type, the product can be split into
Table Product
Inject Product
Others

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players.
To present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Premenstrual Dysphoric Disorder (PMDD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Table Product
1.4.3 Inject Product
1.4.4 Others
1.5 Market by Application
1.5.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size
2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Regions
2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2019-2025)
2.2.2 Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by by Players
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by by Players (2014-2019)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by by Players (2014-2019)
3.1.3 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
3.2 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served
3.3 Key Players Premenstrual Dysphoric Disorder (PMDD) Product/Solution/Service
3.4 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2014-2019)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2014-2019)

5 North America
5.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
5.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in North America
5.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
5.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

6 Europe
6.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
6.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Europe
6.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
6.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

7 China
7.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
7.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in China
7.3 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
7.4 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

8 Japan
8.1 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
8.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Japan
8.3 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
8.4 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
9.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Southeast Asia
9.3 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
9.4 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

10 India
10.1 India Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
10.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in India
10.3 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
10.4 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

11 Central & South America
11.1 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
11.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Central & South America
11.3 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
11.4 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019))
12.1.5 Teva Recent Development
12.2 Eli Liliy
12.2.1 Eli Liliy Company Details
12.2.2 Company Description and Business Overview
12.2.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.2.5 Eli Liliy Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 GSK
12.5.1 GSK Company Details
12.5.2 Company Description and Business Overview
12.5.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.5.5 GSK Recent Development
12.6 Apotex
12.6.1 Apotex Company Details
12.6.2 Company Description and Business Overview
12.6.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.6.5 Apotex Recent Development
12.7 Bristol Laboratories
12.7.1 Bristol Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.7.5 Bristol Laboratories Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.9.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Premenstrual Dysphoric Disorder (PMDD) Key Market Segments
Table Key Players Premenstrual Dysphoric Disorder (PMDD) Covered
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Table Product Figures
Table Key Players of Table Product
Figuer Inject Product Figures
Table Key Players of Inject Product
Figuer Others Figures
Table Key Players of Others
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions 2019-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions 2019-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions 2014-2019
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions 2014-2019
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue by by Players (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Share by by Players (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by by Players in 2018
Table Global Premenstrual Dysphoric Disorder (PMDD) by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Premenstrual Dysphoric Disorder (PMDD) Product/Solution/Service
Table Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Type (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application in 2018
Figure North America Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table North America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table North America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure China Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table China Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table China Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Japan Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure India Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table India Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table India Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Table Teva Company Details
Table Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Teva Recent Development
Table Eli Liliy Company Details
Table Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Eli Liliy Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Bayer Recent Development
Table GSK Company Details
Table GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table GSK Recent Development
Table Apotex Company Details
Table Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Apotex Recent Development
Table Bristol Laboratories Company Details
Table Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Bristol Laboratories Recent Development
Table Mylan Company Details
Table Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Mylan Recent Development
Table Allergan Company Details
Table Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Allergan Recent Development
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (Million US$) 2019-2025
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Regions (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Regions in 2025
Figure North America Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure China Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure India Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product (2019-2025) (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product in 2025
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2025) (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Teva、Eli Liliy、Pfizer、Bayer、GSK、Apotex、Bristol Laboratories、Mylan、Allergan

★調査レポート[月経前不快気分障害（PMDD）の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18853)販売に関する免責事項を必ずご確認ください。
★調査レポート[月経前不快気分障害（PMDD）の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 選択的セロトニン再取り込み阻害薬（SSRI）の世界市場：規模・現状・予測2019-2025
    DATA909X18951 / QYResearch / 2019年11月25日 / ※当調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調査・分析し、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド））、用途別（うつ病、不安およびパニック障害、その他の精神状態）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の選択的セロトニン再取り込み阻害薬（SSRI）市場動向 ・主要企業別マーケットシェア ・選択的セロトニン再取り込み阻害薬（SSRI）の種類別市場規模2014-2019 （シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド）） ・選択的セロトニン再取り込み阻害薬（SSRI）の用途別市場規模2014-2019 （うつ病、不安およびパニック障害、その他の精神状態） ・選択的セロトニン再取り込み阻害薬（SSRI）の北米市場：主要企業・種類別/用途別市場規模 ・選択的セロトニン再取り込み阻害薬（SSRI）のヨーロッパ市場：主要企業・種類別/用途別市場規模...Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy. As a result, the number of vendors manufacturing these drugs is increasing. Moreover, health insurance companies, with support from governments, have started covering treatment expenses related to mental disorder. The rising prevalence of mental illnesses will...
  • 出荷前検査（PSI）の世界市場：規模・現状・予測2019-2025
    DATA909X18856 / QYResearch / 2019年11月25日 / ※当調査レポートでは、出荷前検査（PSI）の世界市場について調査・分析し、出荷前検査（PSI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（社内、外部委託）、用途別（海上輸送、道路輸送、航空輸送）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の出荷前検査（PSI）市場動向 ・主要企業別マーケットシェア ・出荷前検査（PSI）の種類別市場規模2014-2019 （社内、外部委託） ・出荷前検査（PSI）の用途別市場規模2014-2019 （海上輸送、道路輸送、航空輸送） ・出荷前検査（PSI）の北米市場：主要企業・種類別/用途別市場規模 ・出荷前検査（PSI）のヨーロッパ市場：主要企業・種類別/用途別市場規模...A Pre-Shipment Inspection is a systematic inspection of units selected at random from all batches of your order, conducted when your production is at least 80% complete. In 2018, the global Pre-Shipment Inspection (PSI) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pre-Shipment Inspection (PSI) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Shipment Inspection (PSI) development in North America, Europe, China, Japan, Southeast Asia, India and...

    • ◆H&Iグローバルリサーチのお客様（例）◆